Search Results

There are 10695 results for: content related to: Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin

  1. Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

    Journal of Viral Hepatitis

    Volume 22, Issue 12, December 2015, Pages: 992–1001, E. Ogawa, N. Furusyo, K. Dohmen, E. Kajiwara, A. Kawano, H. Nomura, K. Takahashi, T. Satoh, K. Azuma, M. Nakamuta, T. Koyanagi, K. Kotoh, S. Shimoda, J. Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 15 JUN 2015, DOI: 10.1111/jvh.12427

  2. You have free access to this content
    Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 671–685, R. K. Sterling, A. Kuo, V. K. Rustgi, M. S. Sulkowski, T. G. Stewart, J. M. Fenkel, H. El-Genaidi, M. A. Mah'moud, G. M. Abraham, P. W. Stewart, L. Akushevich, D. R. Nelson, M. W. Fried and A. M. Di Bisceglie

    Version of Record online : 28 JAN 2015, DOI: 10.1111/apt.13095

  3. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  4. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  5. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  6. You have free access to this content
    Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1213–1224, V. Saxena, M. M. Manos, H. S. Yee, L. Catalli, E. Wayne, R. C. Murphy, V. A. Shvachko, M. P. Pauly, J. Chua, A. Monto and N. A. Terrault

    Version of Record online : 23 MAR 2014, DOI: 10.1111/apt.12718

  7. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046

  8. You have free access to this content
    Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers

    Hepatology

    Volume 56, Issue 5, November 2012, Pages: 1622–1630, Ellen Hulskotte, Samir Gupta, Fengjuan Xuan, Marga van Zutven, Edward O'Mara, Hwa-Ping Feng, John Wagner and Joan Butterton

    Version of Record online : 14 OCT 2012, DOI: 10.1002/hep.25831

  9. You have free access to this content
    UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 647–662, P. Ramachandran, A. Fraser, K. Agarwal, A. Austin, A. Brown, G. R. Foster, R. Fox, P. C. Hayes, C. Leen, P. R. Mills, D. J. Mutimer, S. D. Ryder and J. F. Dillon

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1365-2036.2012.04992.x

  10. You have free access to this content
    Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 659–671, D. Joshi, I. Carey and K. Agarwal

    Version of Record online : 21 FEB 2013, DOI: 10.1111/apt.12260

  11. Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa-2b

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: 120–127, J. Vermehren, S. Susser, C. M. Lange, N. Forestier, U. Karey, E. Hughes, R. Ralston, X. Tong, S. Zeuzem and C. Sarrazin

    Version of Record online : 1 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01449.x

  12. Chinese community-dwelling elders' needs: promoting ageing in place

    International Nursing Review

    Volume 61, Issue 3, September 2014, Pages: 327–335, M.J. Cao, X.L. Guo, H. Yu, L.Y. Chen and T.A. McDonald

    Version of Record online : 24 JUL 2014, DOI: 10.1111/inr.12119

  13. You have free access to this content
    Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis

    Alimentary Pharmacology & Therapeutics

    Volume 43, Issue 12, June 2016, Pages: 1276–1292, A. Majumdar, M. T. Kitson and S. K. Roberts

    Version of Record online : 18 APR 2016, DOI: 10.1111/apt.13633

  14. You have free access to this content
    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1709–1718, Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 4 AUG 2009, DOI: 10.1002/hep.23192

  15. Dementia and Other Competing Risks for Mortality in the Institutionalized Aged

    Journal of the American Geriatrics Society

    Volume 29, Issue 11, November 1981, Pages: 513–519, PETER PAUL VITALIANO, ARTHUR PECK, DONALD A. JOHNSON, PATRICIA N. PRINZ and CARL EISDORFER

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1981.tb03354.x

  16. You have free access to this content
    Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 6, September 2012, Pages: 560–568, W.-C. Wu, C.-Y. Wu, Y.-J. Wang, H.-H. Hung, H.-I. Yang, W.-Y. Kao, C.-W. Su, J.-C. Wu, W.-L. Chan, H.-C. Lin, F.-Y. Lee and S.-D. Lee

    Version of Record online : 23 JUL 2012, DOI: 10.1111/j.1365-2036.2012.05224.x

  17. You have free access to this content
    Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 567–575, Ira M. Jacobson, Patrick Marcellin, Stefan Zeuzem, Mark S. Sulkowski, Rafael Esteban, Fred Poordad, Savino Bruno, Margaret H. Burroughs, Lisa D. Pedicone, Navdeep Boparai, Weiping Deng, Mark J. DiNubile, Keith M. Gottesdiener, Clifford A. Brass, Janice K. Albrecht and Jean-Pierre Bronowicki

    Version of Record online : 29 JUN 2012, DOI: 10.1002/hep.25865

  18. Boceprevir in liver transplant recipients

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 192–197, Sammy Saab, Vignan Manne, Sherona Bau, Justin A. Reynolds, Ruby Allen, Leonard Goldstein, Francisco Durazo, Mohammed El-Kabany, Steven Han and Ronald W. Busuttil

    Version of Record online : 10 APR 2014, DOI: 10.1111/liv.12548

  19. You have free access to this content
    Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 7, October 2012, Pages: 670–679, I. A. Rowe, D. D. Houlihan and D. J. Mutimer

    Version of Record online : 21 AUG 2012, DOI: 10.1111/apt.12018

  20. You have free access to this content
    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013

    HIV Medicine

    Volume 14, Issue S4, November 2013, Pages: 1–71, Writing Group, Dr Ed Wilkins, Dr Mark Nelson, Dr Kosh Agarwal, Ms Dola Awoyemi, Dr Eleanor Barnes, Dr Sanjay Bhagani, Dr Gary Brook, Dr Ashley Brown, Ms Sheena Castelino, Dr Graham Cooke, Prof Martin Fisher, Prof Anna Maria Geretti, Mr Robert James, Dr Ranjababu Kulasegaram, Prof Clifford Leen, Prof David Mutimer, Dr Chloe Orkin, Dr Emma Page, Dr Adrian Palfreeman, Dr Padmasayee Papineni, Dr Alison Rodger and Dr CY William Tong

    Version of Record online : 25 OCT 2013, DOI: 10.1111/hiv.12106